Results 1 to 10 of about 312,815 (269)
Pentoxifylline for intermittent claudication [PDF]
Медицинский совет, 2015 Obliterating atherosclerosis of the lower extremities leading to a decrease in blood flow occurs in approximately 12% of the population. The pathology is most commonly manifested at the stage of intermittent claudication.
N. A. Vaulin
doaj +6 more sources
Examination of Lower Limb Microcirculation in Diabetic Patients with and without Intermittent Claudication [PDF]
Biomedicines, 2023 Intermittent claudication is a frequent complaint in lower extremity artery disease, but approximately two thirds of patients are asymptomatic, most of which are diabetic patients. Non-invasive angiological and microrheological tests on diabetic subjects
Katalin Biró +8 more
doaj +2 more sources
Illness perception, health literacy, self-efficacy, adherence and quality of life in patients with intermittent claudication – a longitudinal cohort study [PDF]
BMC Nursing, 2023 Background Patients with intermittent claudication need lifelong treatment with secondary prevention to prevent cardiovascular events and progression of atherosclerotic disease.
Rebecka Striberger +3 more
doaj +2 more sources
Revascularization of Peripheral Arteries in Patients with Intermittent Claudication Decreases Inflammatory Biomarkers [PDF]
Clinical and Applied Thrombosis/Hemostasis, 2023 Patients with intermittent claudication have significantly higher levels of inflammatory biomarkers, particularly interleukins, which is also a consequence of exercise limitation.
Pavel Poredoš MD, PhD +4 more
doaj +2 more sources
Patient Reported Experiences of Receiving Person-Centred, Nurse-Led Follow-Up After Revascularisation for Intermittent Claudication: Secondary Analysis of a Randomised Controlled Trial. [PDF]
J Clin NursABSTRACT Aim To evaluate the quality of care from the patients' perspective after receiving either person‐centred, nurse‐led follow‐up or standard care after surgical treatment of intermittent claudication. Design Secondary analysis of a randomised controlled trial.
Haile ST +6 more
europepmc +2 more sources
Journal of Scientific Innovation in Medicine, 2021 Objectives: It is challenging to accurately monitor the progress of intermittent claudication patients during or after treatment. Furthermore, diagnostic tools for intermittent claudication are not always adequate to determine whether other diseases are ...
Mark Greveling +6 more
doaj +1 more source
Scandinavian Journal of Rehabilitation Medicine, 2020 Isokinetic plantar flexor peak torques (PT) and contractional work (CW) of the triceps surae muscle have been measured in 24 patients with peripheral arterial insufficiency and intermittent claudication and in 15 controls.
Björn Gerdle +3 more
semanticscholar +1 more source
BMJ Open Sport & Exercise Medicine, 2020 Peripheral artery disease (PAD) is caused by atherosclerotic narrowing of the arteries supplying the lower limbs often resulting in intermittent claudication, evident as pain or cramping while walking.
A. Harwood +7 more
semanticscholar +1 more source
Journal of Vascular Surgery, 2020 Background: The long-term benefit of revascularization for intermittent claudication is poorly understood. The aim of this study was to investigate the long-term effectiveness and cost-effectiveness compared with a noninvasive approach.
H. Djerf +5 more
semanticscholar +1 more source
Scandinavian Journal of Rehabilitation Medicine, 2020 The possibility of predicting the effect of training on the walking tolerance in intermittent claudication has been studied. After three months of supervised training in 54 patients, the maximal walking distance (MWD) increased by 67% and the painfree ...
T. Jonason, I. Ringqvist
semanticscholar +1 more source